GeneDx Holdings (WGS) EBIAT: 2020-2025
Historic EBIAT for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$7.6 million.
- GeneDx Holdings' EBIAT rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.49%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
- Latest data reveals that GeneDx Holdings reported EBIAT of -$7.6 million as of Q3 2025, which was down 170.64% from $10.8 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' EBIAT ranged from a high of $32.7 million in Q3 2021 and a low of -$308.8 million during Q4 2022.
- Moreover, its 3-year median value for EBIAT was -$20.2 million (2024), whereas its average is -$21.0 million.
- In the last 5 years, GeneDx Holdings' EBIAT spiked by 157.81% in 2021 and then crashed by 668.35% in 2022.
- GeneDx Holdings' EBIAT (Quarterly) stood at -$40.2 million in 2021, then plummeted by 668.35% to -$308.8 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then skyrocketed by 121.10% to $5.4 million in 2024, then climbed by 8.14% to -$7.6 million in 2025.
- Its EBIAT was -$7.6 million in Q3 2025, compared to $10.8 million in Q2 2025 and -$6.5 million in Q1 2025.